[PDF][PDF] The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications.

N Rothwell, S Allan, S Toulmond - The Journal of clinical …, 1997 - Am Soc Clin Investig
The last 5 yr have witnessed significant changes in research direction and new discoveries
about the mechanisms of neurodegeneration. Earlier studies on neuronal death focused on …

[HTML][HTML] Interleukin-1 revisited: further insights into its role in atherosclerosis and as a potential therapeutic target for treatment

KK Ray - Journal of the American College of Cardiology, 2014 - jacc.org
Stable obstructive coronary artery disease (CAD) and acute coronary syndromes (ACS)
result from the complex interplay between genetic factors and environmental exposures over …

Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications

N Potere, MG Del Buono, R Caricchio, PC Cremer… - …, 2022 - thelancet.com
A hyperinflammatory response during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection crucially worsens clinical evolution of coronavirus disease 2019 (COVID…

Dual functionality of interleukin1 family cytokines: implications for anti‐interleukin1 therapy

NM Luheshi, NJ Rothwell… - British journal of …, 2009 - Wiley Online Library
… of IL-1 family intranuclear actions in disease and to assess the therapeutic implications of
these … This could lead to the identification of novel therapeutics to treat inflammatory diseases. …

Interleukin 1 in the brain: biology, pathology and therapeutic target

NJ Rothwell, GN Luheshi - Trends in neurosciences, 2000 - cell.com
… The major signalling receptor for interleukin 1 (IL-1) in mammals is the IL-1RI (80 kDa),
which must associate with an accessory protein (AcP) to elicit signal transductiona. In the brain, …

Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases

DS Hallegua, MH Weisman - Annals of the rheumatic diseases, 2002 - ard.bmj.com
… The cytokines interleukin 1 (IL1) and tumour necrosis factor α (TNFα) are produced acutely
as part … 15 This paper will focus on blocking IL1 as a therapeutic strategy for human disease. …

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

CA Dinarello - Blood, The Journal of the American Society of …, 2011 - ashpublications.org
… IL-1 family are fundamental to innate immunity. Of the 11 members of the IL-1 family, IL-1β
has emerged as a therapeutic … or other parenteral therapies to reduce IL-1 activity. Blocking IL-…

Therapeutic implications of interleukin-10 in inflammatory bowel disease

A SHIRACHI - The Kurume medical journal, 1998 - jstage.jst.go.jp
Enhanced production of proinflammatory cytokines has been described in inflammatory bowel
disease. The effect of interleukin(IL)-10, a cytokine with antiinflammatory activity, or anti-IL-…

Interleukin-1

CA Dinarello - Reviews of infectious diseases, 1984 - academic.oup.com
… The conclusions of this review are (1) that IL-1 is a key mediator of host responses to
microbial invasion, (2) that IL-1 represents a true hormone produced during infection and …

Interleukin-15 biology and its therapeutic implications in cancer

JC Steel, TA Waldmann, JC Morris - Trends in pharmacological sciences, 2012 - cell.com
Cancer immunotherapy is designed to stimulate the immune system to reject and destroy
tumors. Recently, interleukin-15 (IL-15), a member of the four α-helix bundle family of cytokines…